SUBSCRIPTION AGREEMENT

Ben Lytle (“Lytle”)

The L. Ben Lytle Amended and Restated Revocable Living Trust, U/A dated October
20, 2000(“Subscriber”)

Purchaser Representative: N/A

THE SECURITIES REPRESENTED BY THIS INSTRUMENT HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES ACT OF ANY STATE. THE
SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE SOLD OR TRANSFERRED
FOR VALUE IN THE ABSENCE OF AN EFFECTIVE REGISTRATION OF THEM UNDER THE
SECURITIES ACT OF 1933, AS AMENDED, AND/OR APPLICABLE STATE SECURITIES ACTS OR
AN OPINION OF COUNSEL TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED
UNDER SUCH ACT OR ACTS.

THIS INVESTMENT MAY BE SUBJECT TO ADDITIONAL STATE REQUIREMENTS AS SET FORTH
BELOW. INVESTORS SHOULD REFER TO THOSE REQUIREMENTS BEFORE EXECUTING THIS
AGREEMENT.

Healthways, Inc.

3841 Green Hills Village Drive

Nashville, TN 37215

 

Ladies and Gentlemen:

Healthways, Inc., (the “Company”) and Axia Health Management, LLC (“Axia”) have
entered into a Stock Purchase Agreement, dated as of October 11, 2006 (the
“Purchase Agreement”), pursuant to which the Company (or a wholly-owned
subsidiary of the Company) will acquire 100% of the capital stock of Axia Health
Management, Inc. (the “Target”) from Axia (the “Transaction”);

In connection with and subject to consummation of the Transaction, the
Subscriber desires to subscribe for shares of common stock, par value $0.001 per
share (the “Common Stock”) of the Company.

1.            Subscription. The undersigned hereby irrevocably subscribes for
and agrees to purchase 123,305 shares of Common Stock (the “Shares”) at the
closing market price of the Common Stock of the Company on the date of this
Subscription Agreement of $40.55 for an aggregate subscription price of
$5,000,017.75 (the “Purchase Price”), in accordance with the terms and
conditions of this Subscription Agreement.

 

-1-

 

--------------------------------------------------------------------------------

2.            Subscription Closing. The closing on the purchase and sale of the
Shares under this Subscription Agreement (the “ Subscription Closing”) shall
take place at the offices of the Company on the Closing Date (as defined in the
Purchase Agreement), contemporaneously with the consummation of the Transaction.

3.            Deliveries at Subscription Closing; Indemnity Escrow. (a) At the
Subscription Closing, the Company shall deliver to the Subscriber a certificate
for the Shares purchased by the Subscriber, registered in the name of the
Subscriber, against payment to the Company of the Purchase Price by check or
wire transfer of immediately available funds, to an account designated by the
Company; provided that the Company shall withhold from the number of Shares
delivered to the Subscriber that number of Shares as determined in accordance
with Exhibit A (the “Escrow Shares”). For purposes of determining the number of
Escrow Shares to be delivered to the Escrow Agent (as defined in the Purchase
Agreement) pursuant to this Section 3, the Shares will be deemed to have a value
equal to the market closing price of the Common Stock on the date immediately
preceding the Closing Date. As soon as practicable after the Subscription
Closing, and in accordance with the provisions of the Indemnity Escrow Agreement
(as defined in the Purchase Agreement), the Company will cause to be deposited
with the Escrow Agent certificates representing the Escrow Shares, issued in the
name of the Subscriber according to the number of Escrow Shares withheld from
the Subscriber hereunder, together with related stock transfer powers which
shall be delivered by Subscriber.

(b)        The Escrow Agent will hold the Escrow Shares and any dividends and
distributions on the Escrow Shares as collateral for Axia’s indemnification
obligations pursuant to the Purchase Agreement, and shall release such Escrow
Shares and any dividends or distributions thereon in accordance with the terms
of the Escrow Agreement.

 

4.            Representations and Warranties of Undersigned. The undersigned
hereby represents and warrants to the Company that:

(a)          the Subscriber, if an individual, is not less than twenty-one years
of age;

(b)          the Subscriber, either alone or with his or its Purchaser
Representative, if any, named below has such knowledge and experience in
financial and business matters that he is capable of evaluating the merits and
risks of an investment in the Company, and, if a resident of a certain state,
meets any additional suitability standards applicable to him under state law;

 

(c)

if the Subscriber is utilizing a Purchaser Representative for this investment:

(i)           such Purchaser Representative, named at the beginning of this
Agreement, has acted as his or its “Purchaser Representative” as defined in
Regulation D under the Securities Act of 1933, as amended (the “1933 Act”);

 

-2-

 

--------------------------------------------------------------------------------

(ii)          the Subscriber has relied upon the advice of such Purchaser
Representative as to the merits of an investment in the Company and the
suitability of such investment for the Subscriber; and

(iii)        such Purchaser Representative has heretofore confirmed to the
Subscriber in writing (a true and correct copy of which is furnished to the
Company herewith) during the course of this transaction any past, present or
future material relationship, actual or contemplated, between the Purchaser
Representative and/or its affiliates and the Company and/or any of its
affiliates, and any compensation received or to be received as a result thereof;

 

(d)

if the Subscriber is a trust or other entity:

 

(i)

it was not formed for the purpose of this investment;

(ii)          it is authorized and otherwise duly qualified to purchase and hold
Shares; and

(iii)        this Subscription Agreement has been duly and validly authorized
and executed and, when delivered, will constitute the legal, valid, binding and
enforceable obligation of the Subscriber;

(e)          the Subscriber is not subject to a statutory disqualification, as
set forth in Section 3(a)(39) of the 1934 Act;

(f)           the Subscriber and his or its Purchaser Representative, if any,
have been given full and complete access to all information with respect to the
Company and the Company’s proposed activities that the Subscriber and his or its
Purchaser Representative, if any, have deemed necessary to evaluate the merits
and risks of an investment in the Company;

(g)          the Subscriber and, if applicable, his or its Purchaser
Representative, have had a full opportunity to ask questions of and to receive
satisfactory answers from a representative of the Company concerning the terms
and conditions of this investment and all such questions have been answered to
the full satisfaction of the Subscriber;

(h)          the Subscriber and, if applicable, his or its Purchaser
Representative, have had the opportunity to receive documents related to the
Company and to ask questions of and receive answers from the Company regarding
the Company, its business and the terms and conditions of the Offering and have
read carefully copies of the Company’s SEC Filings, including the exhibits
thereto, and the Subscriber is familiar with and agrees to all the terms and
conditions of the offering of Shares;

(i)           the Subscriber is aware of the risks associated with an investment
in the Company, including those described in the “Risk Factors” section of the
Company’s SEC Filings;

 

-3-

 

--------------------------------------------------------------------------------

(j)           the Subscriber has adequate means of providing for his or its
current needs and possible personal contingencies, has no need for liquidity
with respect to his or its investment in the Company, and has financial
resources sufficient to bear the economic risk of such investment;

(k)          the Subscriber has been advised and understands that an investment
in the Company is highly speculative and has received no representations or
warranties from the Company with respect to such investment;

(l)           the Subscriber acknowledges that there are substantial
restrictions on the transferability of, and there will be no public market for,
the Shares and, accordingly, it may not be possible for the Subscriber to
liquidate his or its investment in case of an emergency or otherwise, and the
Subscriber has been advised that while Rule 144 of the 1933 Act is presently
applicable to Shares, the Subscriber understands that Rule 144 may not be
available in the future to the Shares;

(m)         the Subscriber is aware that no securities administrator of any
state or federal government has made or will make any finding or determination
relating to this investment;

(n)          Shares subscribed for hereby are being purchased for the
Subscriber’s own account (or a trust account if the Subscriber is a trustee),
for investment purposes only and are not being purchased with a view to or for
any resale, fractionalization, subdivision or distribution of such Shares; and

(o)          all information which the Subscriber and his or its Purchaser
Representative, if any, has provided to the Company, including (but not limited
to) the information, representations and warranties of the Subscriber contained
in the Purchaser Suitability Statement executed by the Subscriber and submitted
to the Company in connection with this Subscription, is true and correct in all
material respects as of the date set forth below and the Subscriber agrees to
furnish any additional information which the Company may request so as to
determine the suitability of the Subscriber, and to notify the Company
immediately should any material changes in such information occur.

 

5.

Covenants. Lytle and the Subscriber hereby covenant and agree as follows:

(a)          For so long as Lytle is a member of the Company’s board of
directors (the “Board”), (i) Lytle shall at all times, meet the minimum
requirements for stock holdings by members of the Board, as are established by
the Board from time to time, and (ii) the Subscriber shall not Transfer more
than twenty percent (20%) of the Shares then held by the Subscriber in any
calendar year;

(b)          The Subscriber shall not Transfer all or any portion of the Shares
prior to January 1, 2008;

 

-4-

 

--------------------------------------------------------------------------------

(c)          The restrictions set forth in Section 5(a) and 5(b) shall not
apply, and (subject to compliance with applicable securities laws and generally
applicable requirements of the Board with respect to former Board members) the
Subscriber (or his or its successors and/or assigns) shall be permitted to
Transfer the Shares at any time after Lytle ceases to be a member of the Board,
other than as a result of (i) Lytle’s voluntary resignation prior to January 1,
2007 not due a Disability, or (ii) Lytle’s removal from the Board for cause, as
reasonably determined by the Board, in either of which case the restrictions set
forth in Section 5(a)(ii) and Section 6(b) shall remain applicable.

(d)          Notwithstanding anything to the contrary set forth herein, for so
long as any Escrow Shares are held by the Escrow Agent pursuant to the Indemnity
Escrow Agreement, Escrow Shares may be Transferred solely in accordance with and
subject to the terms of the Indemnity Escrow Agreement.

 

(e)

For purposes hereof, the following terms shall have the following meanings:

“Transfer” means any direct or indirect transfer, donation, gift, sale,
assignment, pledge, hypothecation, grant of a security interest in or other
disposal or attempted disposal of all or any portion of a security or of any
rights. “Transferred” means the accomplishment of a Transfer, and “Transferee”
means the recipient of a Transfer.

“Disability” shall mean that the Subscriber is unable, as determined by the
Board (or any designated committee of the Board), to perform the essential
functions of his or its regular duties and responsibilities as a member of the
Board, with or without reasonable accommodation, due in the judgment of a
physician selected by, or reasonably acceptable to the Board, to a physical or
mental illness which has lasted (or can reasonably be expected to last) for a
period of six (6) consecutive months.

6.            Compliance with Federal and State Securities Laws. The undersigned
understands and agrees that the following restrictions and limitations are
applicable to his or its purchase, and any subsequent resale, pledge,
hypothecation or other Transfer of Shares:

(a)          The Shares shall not be sold, pledged, hypothecated or otherwise
Transferred unless such Shares are registered under the 1933 Act and applicable
state securities laws, or the Transfer of such Shares is exempt therefrom.

(b)          A legend in substantially the following form has been or will be
placed on any certificates evidencing Shares:

THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY STATE. THE
SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT PURPOSES, AND MAY NOT BE SOLD OR
TRANSFERRED FOR VALUE IN THE ABSENCE OF AN EFFECTIVE REGISTRATION UNDER THE
SECURITIES ACT OF 1933, AS AMENDED, AND/OR APPLICABLE STATE SECURITIES LAWS OR
AN OPINION OF COUNSEL SATISFACTORY TO THE

 

-5-

 

--------------------------------------------------------------------------------

COMPANY THAT REGISTRATION IS NOT REQUIRED UNDER SUCH ACT OR LAWS.

 

7.

Registration Rights.

(a)          Registration. At the request of the Subscriber, the Company shall
use reasonable commercial efforts to file a registration statement on Form S-3
(or any successor form) (the “Registration Statement”) within thirty (30) days
after the restrictions described in Sections 5(a) and (b) cease, terminate or
lapse with respect to all or part of the Shares (the “Registrable Securities”).
The Company shall use reasonable commercial efforts to cause the Registration
Statement to be declared effective under the Securities Act as promptly as
possible after the filing thereof.

(b)          Delays. The Company may postpone the filing or effectiveness of any
registration statement required pursuant to this Section 7 for a reasonable
period of time, not to exceed one-hundred twenty (120) days in the aggregate, in
any 12-month period, if the Board determines in good faith, that such filing or
effectiveness would (i) reasonably be expected to have a material adverse effect
on (x) any proposal or plan by the Company to engage in any financing,
acquisition, disposition of assets or other plan outside the ordinary course of
business or (y) any merger, consolidation, tender offer or similar transaction,
(ii) require that information which the Board determines in good faith the
disclosure of which would be detrimental to the Company, be disclosed, (iii)
require a special audit of the Company’s financial statements, or (iv) otherwise
be materially detrimental to the Company.

(c)          Expenses. The Company shall pay all expenses incurred by the
Company in connection with the registration, qualification and/or exemption of
the Shares, including any Securities and Exchange Commission (“SEC”) and state
securities law registration and filing fees, printing expenses, fees and
disbursements of the Company’s counsel and accountants, transfer agents’ and
registrars’ fees, fees and disbursements of experts used by the Company in
connection with such registration, qualification and/or exemption, and expenses
incidental to any amendment or supplement to the registration statement or
prospectuses contained therein. The Company shall not, however, be liable for
any sales, broker’s or underwriting commissions upon sale by the Subscriber or
other holder of any of the Shares.

(d)          Registration Period. The Company shall use reasonable commercial
efforts to keep the registration statement required pursuant to Section 7(a)
hereof (the “Registration Statement”) effective pursuant to Rule 415 under the
1933 Act at all times until the earlier of (i) the date on which the Subscriber
shall have sold all the Registrable Securities or (ii) the date on which all
Registrable Securities may be sold without volume restrictions pursuant to Rule
144(k) under the 1933 Act (the “Registration Period”).

 

-6-

 

--------------------------------------------------------------------------------

(e)          Amendments. The Company shall prepare and file with the SEC such
amendments (including post-effective amendments) and supplements to the
Registration Statement and the prospectus used in connection with such
Registration Statement, as may be necessary to keep such Registration Statement
(i) effective at all times during the Registration Period, and, during such
period, comply with the provisions of the 1933 Act with respect to the
disposition of all Registrable Securities of the Company covered by such
Registration Statement and (ii) from containing any untrue statement of a
material fact or omitting to state a material fact required to be stated therein
to make the statements therein, in light of the circumstances in which they were
made, not misleading; provided, that the Company shall be required to notify the
Subscriber, and may suspend sales under such Registration Statement for a period
of up to three months if the Board determines in good faith that to amend or
supplement such Registration Statement would (i) reasonably be expected to have
a material adverse effect on (x) any proposal or plan by the Company to engage
in any financing, acquisition, disposition of assets or other plan outside the
ordinary course of business or (y) any merger, consolidation, tender offer or
similar transaction, (ii) require that information which the Board determines in
good faith the disclosure of which would be detrimental to the Company, be
disclosed, (iii) require a special audit of the Company’s financial statements,
or (iv) otherwise be materially detrimental to the Company, it being understood
that the period for which the Company is obligated to keep the Registration
Statement effective shall be extended for a number of days equal to the number
of days the Company suspends sales under the Registration Statement pursuant to
this provision. Upon receipt of any notice pursuant to this Section 7(e), the
Subscriber shall suspend all offers and sales of securities of the Company and
all use of any prospectus until advised by the Company that offers and sales may
resume, and shall keep confidential the fact and content of any notice given by
the Company pursuant to this Section 7(e).

(f)           State Securities Laws. If qualification or registration under any
state securities laws is required inn connection with such registration, the
Company shall use reasonable commercial efforts to register or qualify the
Registrable Securities covered by such Registration Statement under the
securities laws of such jurisdictions within the United States as the Subscriber
may reasonably request; provided, however, that the Company shall not for any
such purpose be required to qualify generally to transact business as a foreign
corporation in any jurisdiction where it is not so qualified or to consent to
general service of process in any such jurisdiction.

8.            Indemnification of the Company. The undersigned acknowledges and
understands the meaning and legal consequences of the representations and
warranties herein and hereby agrees to indemnify and hold harmless the Company
and its officers, directors, controlling persons, agents, employees, attorneys
and accountants from and against any and all loss, damage or liability, together
with all costs and expenses (including attorneys fees and disbursements) which
any of them may incur by reason of:

(a)          any breach of any representation, warranty or agreement of the
Subscriber contained in this Subscription Agreement; or

 

-7-

 

--------------------------------------------------------------------------------

(b)          any false, misleading or inaccurate information, or any breach of
any representation, warranty or agreement of the Subscriber, contained in the
Purchaser Suitability Statement executed by the Subscriber.

Notwithstanding the foregoing, no representation, warranty, acknowledgment or
agreement made herein by the Subscriber shall in any manner be deemed to
constitute a waiver of any rights of the Subscriber under federal or state
securities laws. All representations, warranties and covenants contained in this
Subscription Agreement and the Purchaser Suitability Statement executed by the
Subscriber, and the indemnification contained in this Section 8, shall survive
the closing of the transactions contemplated hereby.

 

9.

Indemnification of Selling Shareholder. For purposes of this Section 9:

(a)          the term “Selling Shareholder” shall mean the Subscriber, the
directors, officers, partners, members, employees, agents, representatives of,
and each person, if any, who controls the Subscriber within the meaning of
Section 15 of the Securities Act or Section 20 of the Exchange Act;

(b)          the term “Registration Statement” shall include any final
Prospectus, exhibit, supplement or amendment included in or relating to, and any
document incorporated by reference in, the Registration Statement (or deemed to
be a part thereof) referred to in Section7(a); and

(c)          the term “untrue statement” shall mean any untrue statement or
alleged untrue statement, or any omission or alleged omission to state in the
Registration Statement or the a material fact required to be stated therein or
necessary to make the statements therein, in the light of the circumstances
under which they were made not misleading.

(d)          (i)          The Company agrees to indemnify and hold harmless
Selling Shareholder from and against any losses, claims, damages or liabilities
to which such Selling Shareholder may become subject (under the Securities Act
or otherwise) insofar as such losses, claims, damages or liabilities (or actions
or proceedings in respect thereof) arise out of, or are based upon (a) any
untrue statement of a material fact contained in the Registration Statement or
the Prospectus; (b) any inaccuracy in the representations and warranties of the
Company contained in the Agreement or the failure of the Company to perform its
obligations hereunder; or (c) any breach by the Company of any of its
representations and warranties in this Agreement or the failure by the Company
to comply with any agreement or covenant contained in this Agreement or to
fulfill any undertaking included in the Registration Statement, and the Company
will reimburse such Selling Shareholder for any reasonable legal expense or
other actual accountable out of pocket expenses reasonably incurred in
investigating, defending or preparing to defend any such action, proceeding or
claim; provided, however, that the Company shall not be liable in any such case
to the extent that such loss, claim, damage or liability arises out of, or is
based upon, an untrue statement made in such Registration Statement in reliance
upon and in conformity with written information furnished to the

 

-8-

 

--------------------------------------------------------------------------------

Company by such Selling Shareholder specifically for use in preparation of the
Registration Statement, or any inaccuracy in representations made by such
Selling Shareholder herein or in the Subscriber Questionnaire, or the failure of
such Selling Shareholder to comply with its covenants and agreements contained
herein, or any statement or omission prior to the pertinent sale or sales by the
Selling Shareholder.

(ii)                        Promptly after receipt by any indemnified person of
a notice of a claim or the beginning of any action in respect of which indemnity
is to be sought against an indemnifying person pursuant to this Section 9, such
indemnified person shall notify the indemnifying person in writing of such claim
or of the commencement of such action, but the omission to so notify the
indemnifying party will not relieve it from any liability which it may have to
any indemnified party under this Section 9 (except to the extent that such
omission materially and adversely affects the indemnifying party’s ability to
defend such action) or from any liability otherwise than under this Section 9.
Subject to the provisions hereinafter stated, in case any such action shall be
brought against an indemnified person, the indemnifying person shall be entitled
to participate therein, and, to the extent that it shall elect by written notice
delivered to the indemnified party promptly after receiving the aforesaid notice
from such indemnified party, shall be entitled to assume the defense thereof,
with counsel reasonably satisfactory to such indemnified person. After notice
from the indemnifying person to such indemnified person of its election to
assume the defense thereof (unless it has failed to assume the defense thereof
and appoint counsel reasonably satisfactory to the indemnified party), such
indemnifying person shall not be liable to such indemnified person for any legal
expenses subsequently incurred by such indemnified person in connection with the
defense thereof; provided, however, that if there exists or shall exist a
conflict of interest that would make it inappropriate, in the reasonable opinion
of counsel to the indemnified person, for the same counsel to represent both the
indemnified person and such indemnifying person or any affiliate or associate
thereof, the indemnified person shall be entitled to retain its own counsel at
the expense of such indemnifying person; provided, however, that no indemnifying
person shall be responsible for the fees and expenses of more than one separate
counsel (together with appropriate local counsel) for all indemnified parties.
In no event shall any indemnifying person be liable in respect of any amounts
paid in settlement of any action unless the indemnifying person shall have
approved the terms of such settlement; provided that such consent shall not be
unreasonably withheld. No indemnifying person shall, without the prior written
consent of the indemnified person, effect any settlement of any pending or
threatened proceeding in respect of which any indemnified person is or could
reasonably have been a party and indemnification could have been sought
hereunder by such indemnified person, unless such settlement includes an
unconditional release of such indemnified person from all liability on claims
that are the subject matter of such proceeding.

(iii)                       If the indemnification provided for in this Section
9 is unavailable to or insufficient to hold harmless an indemnified party under
subsection (c)(i) and (d) (ii) above in respect of any losses, claims, damages
or

 

-9-

 

--------------------------------------------------------------------------------

liabilities (or actions or proceedings in respect thereof) referred to therein,
then each indemnifying party shall contribute to the amount paid or payable by
such indemnified party as a result of such losses, claims, damages or
liabilities (or actions in respect thereof) in such proportion as is appropriate
to reflect the relative fault of the Company on the one hand and the Subscriber
on the other in connection with the statements or omissions or other matters
which resulted in such losses, claims, damages or liabilities (or actions in
respect thereof), as well as any other relevant equitable considerations. The
relative fault shall be determined by reference to, among other things, in the
case of an untrue statement, whether the untrue statement relates to information
supplied by the Company on the one hand or the Subscriber on the other and the
parties’ relative intent, knowledge, access to information and opportunity to
correct or prevent such untrue statement. The Company and the Subscriber agree
that it would not be just and equitable if contribution pursuant to this
subsection (c) were determined by pro rata allocation or by any other method of
allocation which does not take into account the equitable considerations
referred to above in this subsection (c). The amount paid or payable by an
indemnified party as a result of the losses, claims, damages or liabilities (or
actions in respect thereof) referred to above in this subsection (c) shall be
deemed to include any legal or other expenses reasonably incurred by such
indemnified party in connection with investigating or defending any such action
or claim. Notwithstanding the provisions of this subsection (c), the Subscriber
shall not be required to contribute any amount in excess of the net amount of
the proceeds received by the Subscriber from the sale of the Shares pursuant to
the Registration Statement. No person guilty of fraudulent misrepresentation
(within the meaning of Section 11(f) of the Securities Act) shall be entitled to
contribution from any person who was not guilty of such fraudulent
misrepresentation. The parties to this Agreement hereby acknowledge that they
are sophisticated business persons who were represented by counsel during the
negotiations regarding the provisions hereof including, without limitation, the
provisions of this Section 9, and are fully informed regarding said provisions.
They further acknowledge that the provisions of this Section 9 fairly allocate
the risks in light of the ability of the parties to investigate the Company and
its business in order to assure that adequate disclosure is made in the
Registration Statement as required by the Securities Act and the Exchange Act.

10.          Applicable Law. This Subscription Agreement shall be governed by
and construed in accordance with the laws of the State of Delaware (other than
the choice of laws rules thereof).

11.          Gender. Whenever the singular number is used herein and when
required by the context, the same shall include the plural and the masculine
gender shall include the feminine and, where applicable, shall include any
corporation, firm or partnership executing this Subscription Agreement.

 

-10-

 

--------------------------------------------------------------------------------

12.          Binding Effect. This Subscription Agreement shall be binding upon
and inure to the benefit of the Subscriber and his or its successors and neither
this Subscription Agreement nor any interest herein shall be assignable by him.
This Subscription Agreement shall inure to the benefit of the Company and its
successors and assigns, and upon its acceptance by the Company shall be binding
upon the Company and its successors and assigns.

13.          Joint and Several Representations. Each representation, warranty
and undertaking herein shall be the joint and several representations warranty
and undertaking of Lytle and the Subscriber. If the Subscriber is a partnership,
corporation, trust or other entity, the Subscriber further represents and
warrants that (a) the individual executing this Subscription Agreement on behalf
of the Subscriber has full power and authority to execute and deliver this
Subscription Agreement on behalf of the Subscriber and (b) the Subscriber has
full right and power to perform its obligations pursuant to the provisions
hereof and become a stockholder of the Company.

 

-11-

 

--------------------------------------------------------------------------------

IN WITNESS WHEREOF, the Subscriber has executed and sealed this Subscription
Agreement this _11th__ day of October, 2006.

 

/s/ L. Ben Lytle

L. Ben Lytle

 

The L. Ben Lytle Amended and Restated

Revocable Living Trust, U/A

dated October 20, 2000

 

By: /s/ L. Ben Lytle

 

Name:

Title:

 

-12-

 

--------------------------------------------------------------------------------

 

Subject to the terms and conditions of this Subscription Agreement, the
foregoing subscription is approved and accepted as of the __11th_ day of
October, 2006.

 

HEALTHWAYS, INC.

 

By: /s/ Ben R. Leedle, Jr.

 

Name: Ben R. Leedle, Jr.

 

Title: Chief Executive Officer

 

-13-

 

--------------------------------------------------------------------------------

Exhibit A

Escrow Shares

 

The number of Escrow Shares will be determined at the Subscription Closing by
dividing the dollar value of the Lytle obligation to contribute to the escrow
fund, as determined between Seller and Lytle, held pursuant to the Indemnity
Escrow Agreement (i.e., the sum of the Aggregate Escrow Amount less the Cash
Escrow Fund) by the market closing price per share of the Common Stock on the
date immediately preceding the Closing Date.

 

-14-